Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
Identifieur interne : 001081 ( Istex/Curation ); précédent : 001080; suivant : 001082Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
Auteurs : Stewart A. Factor [États-Unis] ; Kenneth Wolski [États-Unis] ; Daniel M. Togasaki [États-Unis] ; Susan Huyck [États-Unis] ; Marc Cantillon [États-Unis] ; T. W. Ho [États-Unis] ; Robert A. Hauser [États-Unis] ; Emmanuelle Pourcher [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2013-06.
Abstract
Preladenant is a selective adenosine A2A receptor antagonist under investigation for Parkinson's disease treatment.
Url:
DOI: 10.1002/mds.25395
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001081
Links to Exploration step
ISTEX:8A122CC964B6F10850D78C925ED76802C5D82D14Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease</title><author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A." last="Factor">Stewart A. Factor</name><affiliation wicri:level="1"><mods:affiliation>Emory University, Georgia, Atlanta, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Emory University, Georgia, Atlanta</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: sfactor@emory.edu</mods:affiliation><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Wolski, Kenneth" sort="Wolski, Kenneth" uniqKey="Wolski K" first="Kenneth" last="Wolski">Kenneth Wolski</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation></author><author><name sortKey="Togasaki, Daniel M" sort="Togasaki, Daniel M" uniqKey="Togasaki D" first="Daniel M." last="Togasaki">Daniel M. Togasaki</name><affiliation wicri:level="1"><mods:affiliation>University of Southern California, California, Los Angeles, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Southern California, California, Los Angeles</wicri:regionArea></affiliation></author><author><name sortKey="Huyck, Susan" sort="Huyck, Susan" uniqKey="Huyck S" first="Susan" last="Huyck">Susan Huyck</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation></author><author><name sortKey="Cantillon, Marc" sort="Cantillon, Marc" uniqKey="Cantillon M" first="Marc" last="Cantillon">Marc Cantillon</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Wellness Managements Inc, New Jersey, Livingston, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Current Address: Wellness Managements Inc, New Jersey, Livingston</wicri:regionArea></affiliation></author><author><name sortKey="Ho, T W" sort="Ho, T W" uniqKey="Ho T" first="T. W." last="Ho">T. W. Ho</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: AstraZeneca Pharmaceuticals LP, Delaware, Wilmington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Current Address: AstraZeneca Pharmaceuticals LP, Delaware, Wilmington</wicri:regionArea></affiliation></author><author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name><affiliation wicri:level="1"><mods:affiliation>University of South Florida, Florida, Tampa, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of South Florida, Florida, Tampa</wicri:regionArea></affiliation></author><author><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name><affiliation wicri:level="1"><mods:affiliation>Laval University, Quebec, Quebec City, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Laval University, Quebec, Quebec City</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8A122CC964B6F10850D78C925ED76802C5D82D14</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1002/mds.25395</idno><idno type="url">https://api-v5.istex.fr/document/8A122CC964B6F10850D78C925ED76802C5D82D14/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001081</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001081</idno><idno type="wicri:Area/Istex/Curation">001081</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease</title><author><name sortKey="Factor, Stewart A" sort="Factor, Stewart A" uniqKey="Factor S" first="Stewart A." last="Factor">Stewart A. Factor</name><affiliation wicri:level="1"><mods:affiliation>Emory University, Georgia, Atlanta, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Emory University, Georgia, Atlanta</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>E-mail: sfactor@emory.edu</mods:affiliation><country wicri:rule="url">États-Unis</country></affiliation></author><author><name sortKey="Wolski, Kenneth" sort="Wolski, Kenneth" uniqKey="Wolski K" first="Kenneth" last="Wolski">Kenneth Wolski</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation></author><author><name sortKey="Togasaki, Daniel M" sort="Togasaki, Daniel M" uniqKey="Togasaki D" first="Daniel M." last="Togasaki">Daniel M. Togasaki</name><affiliation wicri:level="1"><mods:affiliation>University of Southern California, California, Los Angeles, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of Southern California, California, Los Angeles</wicri:regionArea></affiliation></author><author><name sortKey="Huyck, Susan" sort="Huyck, Susan" uniqKey="Huyck S" first="Susan" last="Huyck">Susan Huyck</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation></author><author><name sortKey="Cantillon, Marc" sort="Cantillon, Marc" uniqKey="Cantillon M" first="Marc" last="Cantillon">Marc Cantillon</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: Wellness Managements Inc, New Jersey, Livingston, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Current Address: Wellness Managements Inc, New Jersey, Livingston</wicri:regionArea></affiliation></author><author><name sortKey="Ho, T W" sort="Ho, T W" uniqKey="Ho T" first="T. W." last="Ho">T. W. Ho</name><affiliation wicri:level="1"><mods:affiliation>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Merck Sharp & Dohme Corp., New Jersey, Whitehouse Station</wicri:regionArea></affiliation><affiliation wicri:level="1"><mods:affiliation>Current Address: AstraZeneca Pharmaceuticals LP, Delaware, Wilmington, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Current Address: AstraZeneca Pharmaceuticals LP, Delaware, Wilmington</wicri:regionArea></affiliation></author><author><name sortKey="Hauser, Robert A" sort="Hauser, Robert A" uniqKey="Hauser R" first="Robert A." last="Hauser">Robert A. Hauser</name><affiliation wicri:level="1"><mods:affiliation>University of South Florida, Florida, Tampa, USA</mods:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>University of South Florida, Florida, Tampa</wicri:regionArea></affiliation></author><author><name sortKey="Pourcher, Emmanuelle" sort="Pourcher, Emmanuelle" uniqKey="Pourcher E" first="Emmanuelle" last="Pourcher">Emmanuelle Pourcher</name><affiliation wicri:level="1"><mods:affiliation>Laval University, Quebec, Quebec City, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Laval University, Quebec, Quebec City</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><date type="published" when="2013-06">2013-06</date><biblScope unit="volume">28</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="817">817</biblScope><biblScope unit="page" to="820">820</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">8A122CC964B6F10850D78C925ED76802C5D82D14</idno><idno type="DOI">10.1002/mds.25395</idno><idno type="ArticleID">MDS25395</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Preladenant is a selective adenosine A2A receptor antagonist under investigation for Parkinson's disease treatment.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001081 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001081 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:8A122CC964B6F10850D78C925ED76802C5D82D14
|texte= Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease
}}
| This area was generated with Dilib version V0.6.29. |  |